Australia vs Belarus: Treatment success rate for patients treated for MDR-TB
Australia
84.0%
in 2022
Belarus
85.0%
in 2022
Australia rank
38th
Belarus rank
35th
Treatment success rate for patients treated for MDR-TB over time
- Australia
- Belarus
How they compare
Belarus currently reports 85.0% against 84.0% in Australia, a difference of 1.0%.
The two have swapped places 3 times across 14 shared years of data; in 2009 it was Australia ahead.
Australia ranks 38th and Belarus ranks 35th of 163 countries.
Across the 3 decades both report, Australia averaged higher in 2 and Belarus in 1.
Head to head by decade
| Decade | Australia | Belarus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.0% | 40.0% | 31.0% | Australia |
| 2010s | 73.4% | 60.5% | 12.9% | Australia |
| 2020s | 75.7% | 82.0% | 6.3% | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Australia or Belarus?
- Belarus, at 85.0% against 84.0% in Australia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Australia and Belarus?
- 1.0%, with Belarus ahead.
- How many years of comparable data are there for Australia and Belarus?
- 14 years are reported by both, from 2009 to 2022.
- How do Australia and Belarus rank globally for treatment success rate for patients treated for mdr-tb?
- Australia ranks 38th and Belarus ranks 35th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.